Capricor Therapeutics Inc... (CAPR)
undefined
undefined%
At close: undefined
13.20
-0.83%
After-hours Dec 13, 2024, 07:52 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Revenue 25.18M 2.55M 244.90K 310.25K 1.01M 1.67M 1.37M 3.19M 3.78M 4.79M 503.23K 195.50K 1.35M - - - 101.40K - - - 2.18K 11.48K - - -
Cost of Revenue 1.07M 694.87K 245.70K 8.46M 5.14M 12.07M 10.77M 16.04M 13.76M 7.79M 5.20M 2.63M - - - - - - - - - - - - -
Gross Profit 24.11M 1.85M -799 -8.15M -4.14M -10.40M -9.40M -12.85M -9.98M -3.00M -4.69M -2.44M 1.35M - - - 101.40K - - - 2.18K 11.48K - - -
Operating Income -24.08M -29.70M -20.94M -13.69M -7.73M -15.33M -12.86M -16.98M -12.61M -6.02M -6.90M -2.44M -4.90M -6.29M -7.88M -13.40M -9.50M -60.40K -18.86K -18.98K -16.16K -17.78K -22.30K -36.52K -200
Interest Income 1.73M - 57.46K 32.94K 94.79K - - - - - - 1.23K 6.01K 20.38K 47.19K 332.71K 287.81K - - - - - - - -
Pretax Income -22.29M -29.02M -20.02M -13.66M -7.64M -15.19M 2.43M -18.81M -12.86M -6.22M -8.89M -1.89M -4.88B -6.03B -7.87B -13.13B -10.30M -61.35K - -18.08K - -15.59K - - -
Net Income -22.29M -29.02M -19.41M -13.48M -7.38M -15.19M 2.43M -18.81M -12.86M -6.22M -8.89M -1.89M -4.88M -6.03M -7.87M -13.13M -10.30M -61.35K -18.86K -18.08K -16.16K -15.59K -22.30K -36.52K -200
Selling & General & Admin 12.37M 10.43M 7.61M 5.54M 3.60M 4.93M 4.76M 4.93M 4.37M 3.02M 2.21M 1.61M 2.12M 2.21M 3.42M 3.92M 4.48M 60.40K 18.86K 18.98K 18.34K 29.26K 22.22K 10.43K -
Research & Development 36.45M 21.82M 13.57M 8.46M 5.14M 12.07M 10.77M 16.04M 13.76M 7.79M 5.20M 1.02M 4.14M 4.08M 4.47M 9.48M 5.12M - - - - - - - -
Other Expenses - 190.58K 548.21K - - - - - - - - 545.88K - - - - - - - - - - 83.00 26.09K 200.00
Operating Expenses 48.19M 32.25M 21.18M 14.00M 8.74M 17.00M 14.23M 20.17M 16.39M 10.80M 7.41M 2.64M 6.25M 6.29M 7.88M 13.40M 9.60M 60.40K 18.86K 18.98K 18.34K 29.26K 22.30K 36.52K 200.00
Interest Expense - - - - - - 398.81K 344.67K 248.63K 200.50K 58.13K - - - - 137.00 1.09M 950.00 - - - - - - -
Selling & Marketing Expenses - - - - - - - - - - - - - - - - - - - - - - - 10.43K -
Cost & Expenses 49.26M 32.25M 21.18M 14.00M 8.74M 17.00M 14.23M 20.17M 16.39M 10.80M 7.41M 2.64M 6.25M 6.29M 7.88M 13.40M 9.60M 60.40K 18.86K 18.98K 18.34K 29.26K 22.30K 36.52K 200.00
Income Tax - -677.85 -613.41K -176.83K -264.03K 135.99K 254.63K 218.95K 137.76K 200.50K 58.13K - -14.39K -262.06K -11.41K -268.39K 1.09M - 18.86K - 16.16K - - - 200.00
Shares Outstanding (Basic) 26.78M 24.55M 23.09M 15.57M 3.71M 2.94M 2.32M 1.86M 1.59M 1.17M 1.05M 994.52K 74.66K 64.34K 50.93K 48.25K 33.88K 27.59K 1.51K 1.51K 1.51K 1.51K 1.51K 1.38K 1K
Shares Outstanding (Diluted) 26.78M 24.55M 23.09M 15.57M 3.71M 2.94M 2.68M 1.86M 1.59M 1.17M 1.05M 994.52K 74.66K 64.34K 50.93K 48.25K 33.88K 27.59K 1.51K 1.51K 1.51K 1.51K 1.51K 1.38K 1K
EPS (Basic) -0.83 -1.18 -0.84 -0.87 -1.99 -5.17 1.00 -10.14 -8.09 -5.31 -8.47 -1.9 -65.43 -93.75 -154.56 -272.15 -304.06 -2.22 -12.49 -11.97 -10.7 -10.32 -14.77 -26.56 -0.2
EPS (Diluted) -0.83 -1.18 -0.84 -0.87 -1.99 -5.17 0.90 -10.14 -8.09 -5.31 -8.47 -1.9 -65.43 -93.75 -154.56 -272.15 -304.06 -2.22 -12.49 -11.97 -10.7 -10.32 -14.77 -26.56 -0.2
EBITDA -23.01M -29.16M -20.69M -13.55M -7.56M -15.17M -12.72M -18.33M -12.50M -5.97M -6.88M -1.89M -4.88M -6.02M -7.71M -13.02M -9.50M -2.50M -18.86K -19.88K -16.16K -19.97K -22.22K -36.32K 200.00
Depreciation & Amortization 1.07M 694.87K 245.70K 143.89K 171.96K 157.65K 144.17K 134.64K 110.86K 41.90K 26.92K 6.26K 7.51K 12.93K 159.59K 113.29K 26.98K - - -900 - -2.19K 83.00 200.00 200.00